Development of Discharge Education Video for Solid Organ Transplant Recipients

Audiovisual teaching aids can play a significant role for the retention of new material and help overcome barriers such as the physical presence or time restrictions of an instructor. In a clinical setting, multimedia health education can offer an advantage over traditional didactic teaching by engaging patients through visual content and unlimited accessibility.

A critical factor to long-term survival of solid organ transplant recipients is compliance to post-transplantation medication and follow-up patient care. Transplant pharmacists serve on multidisciplinary care teams as the medication experts that provide discharge education to recipients and caregivers often at the bedside. The adoption of digital multimedia content for patient education can increase engagement of diverse learning styles while simultaneously reducing potential time conflicts in hospital practice. This study contributes to the literature by assessing the effectiveness of discharge education video(s) on patient satisfaction and knowledge levels which are currently limited.

Study Overview

• Status: Completed
• Conditions: Educational Activities; Organ Transplants
• Intervention / Treatment: Other: Educational Videos

• Study Type: Interventional
• Enrollment (Actual): 24
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Maryland
    • Baltimore, Maryland, United States, 21287
      • Johns Hopkins Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Patients who are solid organ transplant recipients at Johns Hopkins Hospital
• Patients who are being managed by an adult solid-organ transplant surgical service
• Patients who can speak and read the English language

Exclusion Criteria:

• Patients with language access services needs will be excluded
• Patients who do not meet inclusion criteria

Study Plan

How is the study designed?

Design Details

• Primary Purpose: HEALTH_SERVICES_RESEARCH
• Allocation: NON_RANDOMIZED
• Interventional Model: PARALLEL
• Masking: NONE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
NO_INTERVENTION: Standard of Care; Patients in the Standard of Care arm will receive pharmacist discharge education via fully in-person education as is currently being done.
EXPERIMENTAL: Intervention; Patients in the Intervention arm will have access to pre-recorded educational videos covering key educational points. Patients will also have in-person interaction with pharmacists to address additional questions not covered in the videos.	Other: Educational Videos; Series of six videos each covering a specific aspect of post-transplant care related to medication use or monitoring

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Patient Transplant Medication and Care Knowledge	Change in performance pre and post-education based on responses to questionnaire	Pre- and post-education; pre-education assessment will be completed as soon as feasible after transplant (estimate 1-3 days) and consent; post-education assessment will be completed as soon as is feasible after initial education (estimate 0-2 days)
Patient Satisfaction with Educational Method	Difference in satisfaction as determined by response to questionnaire post education. A single question score from 1 to 10 will be used, with 10 being highest satisfaction and 1 being the lowest level of satisfaction	As soon as feasible post-education, in concert with post-education knowledge assessment (estimate 0-2 days)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pharmacist Time Requirement	Time required by pharmacist for education	As soon as feasible post-education (estimate 0-2 days)

Collaborators and Investigators

• Sponsor: Johns Hopkins University
• Investigators: Principal Investigator: Ryan Whisler, Johns Hopkins University

Study record dates

Study Major Dates

• Study Start (ACTUAL): April 11, 2022
• Primary Completion (ACTUAL): June 3, 2022
• Study Completion (ACTUAL): June 3, 2022

Study Registration Dates

• First Submitted: December 29, 2021
• First Submitted That Met QC Criteria: December 29, 2021
• First Posted (ACTUAL): January 12, 2022

Study Record Updates

• Last Update Posted (ACTUAL): June 8, 2022
• Last Update Submitted That Met QC Criteria: June 7, 2022
• Last Verified: May 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: IRB00303596

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No